| Year |
Citation |
Score |
| 2019 |
Jurecic R. Hematopoietic Stem Cell Heterogeneity. Advances in Experimental Medicine and Biology. 1169: 195-211. PMID 31487025 DOI: 10.1007/978-3-030-24108-7_10 |
0.515 |
|
| 2019 |
Rodriguez Valentin M, Rivas D, Jurecic V, Diaz A, Riley R, Frasca D, Jurecic R. Cellular and Molecular Characterization of Breast Cancer Chemotherapy-Related B Cell Lymphomas Blood. 134: 5241-5241. DOI: 10.1182/Blood-2019-127252 |
0.43 |
|
| 2019 |
Barreras H, Bader CS, Copsel S, Kale B, Pfeiffer BJ, Lozano C, Lightbourn CO, Jurecic R, Levy RB. Development of a Concomitant Treg Expansion and Stem Cell Mobilization Protocol Which Enables Peripheral Blood Transplant Amelioration of Gvhd Following Pre-Clinical aHSCT Biology of Blood and Marrow Transplantation. 25: S292. DOI: 10.1016/J.Bbmt.2018.12.668 |
0.436 |
|
| 2015 |
Russell KB, Theall BP, Hernandez L, Wavering HM, Jurecic V, Andreansky S, Levy RB, Jurecic R. Novel Multi-Target Immunosuppressive Approach for Treatment of Severe Aplastic Anemia Blood. 126: 3611-3611. DOI: 10.1182/Blood.V126.23.3611.3611 |
0.424 |
|
| 2014 |
Weston W, Zayas J, Perez R, George J, Jurecic R. Dynamic equilibrium of heterogeneous and interconvertible multipotent hematopoietic cell subsets. Scientific Reports. 4: 5199. PMID 24903657 DOI: 10.1038/Srep05199 |
0.569 |
|
| 2014 |
Lorente J, Kannegenti D, Theall B, Hernandez L, Vallabhaneni E, Jurecic V, Gupta V, Adkins B, Jurecic R. Novel Immunosuppressive Approach Attenuates Severe Aplastic Anemia in Mouse Lymphocyte Infusion AA Models Blood. 124: 2942-2942. DOI: 10.1182/Blood.V124.21.2942.2942 |
0.436 |
|
| 2013 |
Weston W, Gupta V, Adkins R, Jurecic R. New therapeutic approaches for protecting hematopoietic stem cells in aplastic anemia. Immunologic Research. 57: 34-43. PMID 24203441 DOI: 10.1007/S12026-013-8449-0 |
0.433 |
|
| 2012 |
Jurecic R, Li L, Humphries RK. Heterogeneity, self-renewal, and differentiation of hematopoietic stem cells. Stem Cells International. 2012: 580165. PMID 22685474 DOI: 10.1155/2012/580165 |
0.545 |
|
| 2010 |
Urbieta M, Barao I, Jones M, Jurecic R, Panoskaltsis-Mortari A, Blazar BR, Murphy WJ, Levy RB. Hematopoietic progenitor cell regulation by CD4+CD25+ T cells. Blood. 115: 4934-43. PMID 20200356 DOI: 10.1182/Blood-2009-04-218826 |
0.478 |
|
| 2009 |
Kutlesa S, Zayas J, Valle A, Levy RB, Jurecic R. T-cell differentiation of multipotent hematopoietic cell line EML in the OP9-DL1 coculture system. Experimental Hematology. 37: 909-23. PMID 19447159 DOI: 10.1016/J.Exphem.2009.05.002 |
0.527 |
|
| 2008 |
Jing X, Infante J, Nachtman RG, Jurecic R. E3 ligase FLRF (Rnf41) regulates differentiation of hematopoietic progenitors by governing steady-state levels of cytokine and retinoic acid receptors. Experimental Hematology. 36: 1110-20. PMID 18495327 DOI: 10.1016/J.Exphem.2008.04.001 |
0.474 |
|
| 2008 |
Zayas J, Spassov DS, Nachtman RG, Jurecic R. Murine hematopoietic stem cells and multipotent progenitors express truncated intracellular form of c-kit receptor. Stem Cells and Development. 17: 343-53. PMID 18447649 DOI: 10.1089/Scd.2007.0101 |
0.783 |
|
| 2008 |
Kuçi S, Kuçi Z, Schmid S, Seitz G, Müller I, Dufke A, Leimig T, Murti G, Jurecic R, Schumm M, Lang P, Bruchelt G, Bader P, Klingebiel T, Niethammer D, et al. Efficient in vitro generation of adult multipotent cells from mobilized peripheral blood CD133+ cells. Cell Proliferation. 41: 12-27. PMID 18211283 DOI: 10.1111/J.1365-2184.2007.00502.X |
0.434 |
|
| 2007 |
Liang H, Coles AH, Zhu Z, Zayas J, Jurecic R, Kang J, Jones SN. Noncanonical Wnt signaling promotes apoptosis in thymocyte development. The Journal of Experimental Medicine. 204: 3077-84. PMID 18070933 DOI: 10.1084/Jem.20062692 |
0.423 |
|
| 2007 |
Zayas J, George J, Nachtman RG, Jurecic R. Varying Levels of CD34 Expression Correlate with Maintenance and Differentiation of HSC/MPP-Like Cell Line EML. Blood. 110: 4050-4050. DOI: 10.1182/Blood.V110.11.4050.4050 |
0.482 |
|
| 2007 |
Zayas J, George J, Nachtman R, Jurecic R. RNA-Binding Protein Pum2 Promotes Self-Renewal and Suppresses Differentiation of Multipotent Hematopoietic Cells by Maintaining Them in Inactive CD34− State. Blood. 110: 2231-2231. DOI: 10.1182/Blood.V110.11.2231.2231 |
0.57 |
|
| 2006 |
Yang J, Di Vito K, Nachtman RG, Jurecic R. By Maintaining Cells in an Inactive CD34− State RNA-Binding Protein Pum2 Promotes Proliferation and Inhibits Differentiation of Multipotent Hematopoietic Cells. Blood. 108: 1354-1354. DOI: 10.1182/Blood.V108.11.1354.1354 |
0.502 |
|
| 2006 |
Zayas J, Spassov DS, Saltiel CI, Nachtman RG, Jurecic R. Hematopoietic Stem Cells and Multipotent Progenit c-Kit Receptor: Indication of an Alternative c-Kit Signaling Pathway. Blood. 108: 1323-1323. DOI: 10.1182/Blood.V108.11.1323.1323 |
0.764 |
|
| 2005 |
Yang J, Saltiel CI, Nachtman RG, Jing X, Jurecic R. The Role of Truncated c-kit Receptor (tr-kit) in Maintenance and Differentiation of Hematopoietic Stem Cells and Multipotent Hematopoietic Progenitors. Blood. 106: 4193-4193. DOI: 10.1182/Blood.V106.11.4193.4193 |
0.674 |
|
| 2005 |
Jing X, Dabul L, Nachtman RG, Jurecic R. IL-3 and Retinoic Acid-Induced Myeloid Differentiation of Hematopoietic Progenitors Is Negatively Regulated by E3 Ubiquitin Ligase Rnf41 (FLRF). Blood. 106: 3160-3160. DOI: 10.1182/Blood.V106.11.3160.3160 |
0.426 |
|
| 2004 |
Jing X, Dabul L, Mnayer LO, Jurecic R. E3 Ubiquitin Ligase Rnf41 (FLRF/Nrdp1) Regulates Steady-State Cytokine Receptor Levels in Multipotent Hematopoietic Progenitors. Blood. 104: 461-461. DOI: 10.1182/Blood.V104.11.461.461 |
0.566 |
|
| 2004 |
Yang J, Spassov DS, Nachtman RG, Jurecic R. Pum2 Protein Supports Maintenance and Suppresses Differentiation of Multipotent Hematopoietic Progenitors by Regulating the Function and Activation of c-kit Receptor. Blood. 104: 1692-1692. DOI: 10.1182/Blood.V104.11.1692.1692 |
0.783 |
|
| 2003 |
Liang H, Chen Q, Coles AH, Anderson SJ, Pihan G, Bradley A, Gerstein R, Jurecic R, Jones SN. Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue. Cancer Cell. 4: 349-60. PMID 14667502 DOI: 10.1016/S1535-6108(03)00268-X |
0.504 |
|
| 2003 |
Spassov DS, Jurecic R. The PUF family of RNA-binding proteins: does evolutionarily conserved structure equal conserved function? Iubmb Life. 55: 359-66. PMID 14584586 DOI: 10.1080/15216540310001603093 |
0.723 |
|
| 2003 |
Spassov DS, Jurecic R. Mouse Pum1 and Pum2 genes, members of the Pumilio family of RNA-binding proteins, show differential expression in fetal and adult hematopoietic stem cells and progenitors. Blood Cells, Molecules & Diseases. 30: 55-69. PMID 12667987 DOI: 10.1016/S1079-9796(03)00003-2 |
0.786 |
|
| 2003 |
Komatsu M, Mammolenti M, Jones M, Jurecic R, Sayers TJ, Levy RB. Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing. Blood. 101: 3991-9. PMID 12521999 DOI: 10.1182/Blood-2002-09-2859 |
0.372 |
|
| 2002 |
Spassov DS, Jurecic R. Cloning and comparative sequence analysis of PUM1 and PUM2 genes, human members of the Pumilio family of RNA-binding proteins. Gene. 299: 195-204. PMID 12459267 DOI: 10.1016/S0378-1119(02)01060-0 |
0.718 |
|
| 2002 |
Chen AJ, Zhou G, Juan T, Colicos SM, Cannon JP, Cabriera-Hansen M, Meyer CF, Jurecic R, Copeland NG, Gilbert DJ, Jenkins NA, Fletcher F, Tan TH, Belmont JW. The dual specificity JKAP specifically activates the c-Jun N-terminal kinase pathway Journal of Biological Chemistry. 277: 36592-36601. PMID 12138158 DOI: 10.1074/Jbc.M200453200 |
0.421 |
|
| 2001 |
Abdullah JM, Jing X, Spassov DS, Nachtman RG, Jurecic R. Cloning and characterization of Hepp, a novel gene expressed preferentially in hematopoietic progenitors and mature blood cells. Blood Cells, Molecules & Diseases. 27: 667-76. PMID 11482882 DOI: 10.1006/Bcmd.2001.0434 |
0.777 |
|
| 2001 |
Abdullah JM, Li X, Nachtman RG, Jurecic R. FLRF, a novel evolutionarily conserved RING finger gene, is differentially expressed in mouse fetal and adult hematopoietic stem cells and progenitors. Blood Cells, Molecules & Diseases. 27: 320-33. PMID 11358394 DOI: 10.1006/Bcmd.2001.0390 |
0.619 |
|
| 2000 |
Jurecic R, Belmont JW. Long-distance DD-PCR and cDNA microarrays. Current Opinion in Microbiology. 3: 316-21. PMID 10851166 DOI: 10.1016/S1369-5274(00)00096-5 |
0.416 |
|
| 2000 |
Nachtman RG, Abdullah JM, Jurecic R, Lemischka ibI. Cloning and functional characterization of novel genes preferentially expressed in hematopoietic cells Experimental Hematology. 28: 108. DOI: 10.1016/S0301-472X(00)00423-9 |
0.557 |
|
| 2000 |
Nachtman RG, Abdullah JM, Infante JL, Jurecic R, Lemischka ibI. Screening, cloning and characterization of novel transcription factors involved in blood cell development Experimental Hematology. 28: 108. DOI: 10.1016/S0301-472X(00)00422-7 |
0.592 |
|
| 2000 |
Nachtman RG, Jurecic R, Lemischka ibI. Microinjection of purified transgenic hsc and progenitors into blastocysts leads to partial complementation of t cell compartment in chimeric adult RAG-2 mice Experimental Hematology. 28: 108. DOI: 10.1016/S0301-472X(00)00421-5 |
0.459 |
|
| 1998 |
Jurecic R, Nachtman RG, Colicos SM, Belmont JW. Identification and cloning of differentially expressed genes by long-distance differential display. Analytical Biochemistry. 259: 235-44. PMID 9618202 DOI: 10.1006/Abio.1998.2653 |
0.394 |
|
| 1997 |
Belmont JW, Jurecic R. Methods for efficient retrovirus-mediated gene transfer to mouse hematopoietic stem cells. Methods in Molecular Medicine. 7: 223-40. PMID 24493430 DOI: 10.1385/0-89603-484-4:223 |
0.547 |
|
| 1996 |
Jurecic R, Nguyen T, Belmont JW. Differential mRNA display using anchored oligo-dT and long sequence-specific primers as arbitrary primers. Trends in Genetics : Tig. 12: 502-4. PMID 9257529 DOI: 10.1016/S0168-9525(96)90045-1 |
0.327 |
|
| 1993 |
Jurecic R, Van N, Belmont J. Enrichment and functional characterization of Sca-1+WGA+, Lin-WGA+, Lin- Sca-1+, and Lin-Sca-1+WGA+ bone marrow cells from mice with an Ly-6a haplotype Blood. 82: 2673-2683. DOI: 10.1182/Blood.V82.9.2673.Bloodjournal8292673 |
0.501 |
|
| 1989 |
Volf D, Jurecic R. Cell staining with DAPI: or dead? Trends in Genetics. 5: 292. DOI: 10.1016/0168-9525(89)90107-8 |
0.355 |
|
| Show low-probability matches. |